How to Build a Next-gen MRNA Company to Combat Cancer
Event by Cure.
UTR Therapeutics CEO and genome engineer Dr. Chidiebere Awah joins Cure CEO Seema Kumar to explain the science and how he developed his company to deploy first–in–class mRNA overwriting therapies and what this means for a wide range of diseases and disorders.
